X-136656377-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM5PP3_Moderate
The ENST00000370629.7(CD40LG):c.368C>T(p.Ala123Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000663 in 1,207,416 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A123E) has been classified as Pathogenic.
Frequency
Consequence
ENST00000370629.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD40LG | NM_000074.3 | c.368C>T | p.Ala123Val | missense_variant | 4/5 | ENST00000370629.7 | NP_000065.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD40LG | ENST00000370629.7 | c.368C>T | p.Ala123Val | missense_variant | 4/5 | 1 | NM_000074.3 | ENSP00000359663 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000894 AC: 1AN: 111834Hom.: 0 Cov.: 23 AF XY: 0.0000294 AC XY: 1AN XY: 34012
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183016Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67634
GnomAD4 exome AF: 0.00000639 AC: 7AN: 1095528Hom.: 0 Cov.: 29 AF XY: 0.00 AC XY: 0AN XY: 361052
GnomAD4 genome AF: 0.00000894 AC: 1AN: 111888Hom.: 0 Cov.: 23 AF XY: 0.0000293 AC XY: 1AN XY: 34076
ClinVar
Submissions by phenotype
Hyper-IgM syndrome type 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 02, 2022 | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CD40LG protein function. ClinVar contains an entry for this variant (Variation ID: 423253). This variant has not been reported in the literature in individuals affected with CD40LG-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 123 of the CD40LG protein (p.Ala123Val). This variant disrupts the p.Ala123 amino acid residue in CD40LG. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8094231, 10559240, 15623492). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 09, 2017 | The A123V variant in the CD40LG gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. However a different missense variant at this same codon (A123E) has been reported in a child with hyper-IgM syndrome (DiSanto et al., 1993). While the diagnosis of hyper-IgM was confirmed by lack of CD40LG seen in stimulated T-cells from this individual, further evidence supporting the pathogenicity of the A123E variant, such as functional studies on this specific variant, were not provided (DiSanto et al., 1993). The A123V variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The A123V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Based on the information available, we interpret A123V as a variant of uncertain clinical significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at